SEED THERAPEUTICS Trademark

Trademark Overview


On Wednesday, August 27, 2025, a trademark application was filed for SEED THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the SEED THERAPEUTICS trademark a serial number of 99361623. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, August 27, 2025. This trademark is owned by SEED Therapeutics US, Inc.. The SEED THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

drug discovery, development and validation services; pharmaceutical research and development; providing medical research and scientific information in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; providing scientific, pharmaceutical, clinical and medical research information via the internet; consulting services in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; research and development of new products; scientific, medical and clinical research and development services; providing information, scientific, pharmaceutical, clinical, and medical research, drug discovery, development and validation, and consulting services with respect to identifying ubiquitin ligases; providing information, scientific, pharmaceutical, clinical and medical research, drug discovery, development and validation, and consulting services with respect to using a photocatalyst molecule for labeling a protei...
seed therapeutics

General Information


Serial Number99361623
Word MarkSEED THERAPEUTICS
Filing DateWednesday, August 27, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateWednesday, August 27, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicesdrug discovery, development and validation services; pharmaceutical research and development; providing medical research and scientific information in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; providing scientific, pharmaceutical, clinical and medical research information via the internet; consulting services in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; research and development of new products; scientific, medical and clinical research and development services; providing information, scientific, pharmaceutical, clinical, and medical research, drug discovery, development and validation, and consulting services with respect to identifying ubiquitin ligases; providing information, scientific, pharmaceutical, clinical and medical research, drug discovery, development and validation, and consulting services with respect to using a photocatalyst molecule for labeling a protein proximate to a target disease-causing protein within a live cell

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, August 27, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSEED Therapeutics US, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKing of Prussia, PA 19406

Trademark Events


Event DateEvent Description
Wednesday, August 27, 2025NEW APPLICATION ENTERED
Wednesday, August 27, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 27, 2025APPLICATION FILING RECEIPT MAILED